Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argon ventilation for post-cardiac arrest
NCT05482945Phase 2Recruiting
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- May 2022
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in cardiac arrest (SCA) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Neuronal preservation (Serum Neuron-Specific Enolase) at 48 hours. Started May 2022; status: recruiting.
02
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT05482945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05482945.